目的:探讨骨水泥型人工双极股骨头置换治疗股骨近段转移瘤的临床疗效。方法:回顾性分析2012年1月至2019年6月华中科技大学同济医学院附属协和医院收治的54例行骨水泥型人工双极股骨头置换的股骨近段转移瘤患者的资料。采用疼痛视觉模拟...目的:探讨骨水泥型人工双极股骨头置换治疗股骨近段转移瘤的临床疗效。方法:回顾性分析2012年1月至2019年6月华中科技大学同济医学院附属协和医院收治的54例行骨水泥型人工双极股骨头置换的股骨近段转移瘤患者的资料。采用疼痛视觉模拟评分(visual analogue scale,VAS)、国际骨肿瘤协会(musculoskeletal tumor society system,MSTS)功能评分、国际保肢学会(international society of limb salvage,ISOLS)影像评分、Harris髋关节功能评分量表(Harris hip score)、Karnofsky功能状态(Karnofsky performance status,KPS)评分和诺丁汉健康调查问卷(Nottingham health profile,NHP)评分评定患者疼痛、肢体功能和生存质量。Kaplan-Meier法分析生存情况。结果:患者随访时间为10~99个月,平均42.17个月。患者手术时间(79.68±6.17)min,术中出血量(524.00±39.25)mL。术后3、6和12个月,VAS评分和NHP评分分别较术前降低,MSTS评分、ISOLS评分、Harris评分和KPS评分分别较术前提高,差异均具有统计学意义(P<0.05)。术后3、6和12个月,每个随访点之间的VAS评分、相关功能评分和生存质量评分差异均无统计学意义(P>0.05)。随访期内6例发生并发症。患者平均生存时间19.46个月,6个月、1年和3年生存率分别为88.89%、70.37%和11.11%。结论:股骨近段骨转移瘤患者行骨水泥型人工双极股骨头置换可减轻患者疼痛,提高肢体功能,延长生存时间,提高生存质量。展开更多
Objective: Radiotherapy has been widely used to treat lung cancer. However, non-small lung cancer cells are insensitive to radiation, diminishing their radiotherapy effects. Although the radiosensitivity of the non-sm...Objective: Radiotherapy has been widely used to treat lung cancer. However, non-small lung cancer cells are insensitive to radiation, diminishing their radiotherapy effects. Although the radiosensitivity of the non-small lung cancer cells was reported to be enhanced through regulating miR-34a, the regulation effects of miR-34a expression on radiosensitivity of lung adenocarcinoma cells through target genes CDK4, CDK6, CyclinD1, and Bcl-2/Bax have not been systematically investigated. Methods: In this study, we investigated the effect of miR-34a expression on the Bcl-2, CDK4, and CDK6 pathways in lung adenocarcinoma cells, to provide new insights into the sensitization treatment of lung cancer. We first studied the effect of miR-34a expression on H1299 and A549 cell activity. Then to investigate the mechanisms of radiosensitivity, we focused on apoptosis, cell cycle, and target genes. Results: We find that overexpression of miR-34a in lung adenocarcinoma cells inhibits cell activity, and improves radiosensitivity. Specifically, overexpression of miR-34a suppresses the expression of target genes CDK4, CDK6, CyclinD1, and Bcl-2/Bax, which leads to cell cycle arrest and promotes apoptosis of lung adenocarcinoma cells. Conclusions: Overall, our results demonstrate that the overexpression of miR-34a enhances the radiosensitivity of lung adenocarcinoma cells, indicating that miR-34a is a sensitizer for lung adenocarcinoma radiotherapy.展开更多
文摘目的:探讨骨水泥型人工双极股骨头置换治疗股骨近段转移瘤的临床疗效。方法:回顾性分析2012年1月至2019年6月华中科技大学同济医学院附属协和医院收治的54例行骨水泥型人工双极股骨头置换的股骨近段转移瘤患者的资料。采用疼痛视觉模拟评分(visual analogue scale,VAS)、国际骨肿瘤协会(musculoskeletal tumor society system,MSTS)功能评分、国际保肢学会(international society of limb salvage,ISOLS)影像评分、Harris髋关节功能评分量表(Harris hip score)、Karnofsky功能状态(Karnofsky performance status,KPS)评分和诺丁汉健康调查问卷(Nottingham health profile,NHP)评分评定患者疼痛、肢体功能和生存质量。Kaplan-Meier法分析生存情况。结果:患者随访时间为10~99个月,平均42.17个月。患者手术时间(79.68±6.17)min,术中出血量(524.00±39.25)mL。术后3、6和12个月,VAS评分和NHP评分分别较术前降低,MSTS评分、ISOLS评分、Harris评分和KPS评分分别较术前提高,差异均具有统计学意义(P<0.05)。术后3、6和12个月,每个随访点之间的VAS评分、相关功能评分和生存质量评分差异均无统计学意义(P>0.05)。随访期内6例发生并发症。患者平均生存时间19.46个月,6个月、1年和3年生存率分别为88.89%、70.37%和11.11%。结论:股骨近段骨转移瘤患者行骨水泥型人工双极股骨头置换可减轻患者疼痛,提高肢体功能,延长生存时间,提高生存质量。
文摘Objective: Radiotherapy has been widely used to treat lung cancer. However, non-small lung cancer cells are insensitive to radiation, diminishing their radiotherapy effects. Although the radiosensitivity of the non-small lung cancer cells was reported to be enhanced through regulating miR-34a, the regulation effects of miR-34a expression on radiosensitivity of lung adenocarcinoma cells through target genes CDK4, CDK6, CyclinD1, and Bcl-2/Bax have not been systematically investigated. Methods: In this study, we investigated the effect of miR-34a expression on the Bcl-2, CDK4, and CDK6 pathways in lung adenocarcinoma cells, to provide new insights into the sensitization treatment of lung cancer. We first studied the effect of miR-34a expression on H1299 and A549 cell activity. Then to investigate the mechanisms of radiosensitivity, we focused on apoptosis, cell cycle, and target genes. Results: We find that overexpression of miR-34a in lung adenocarcinoma cells inhibits cell activity, and improves radiosensitivity. Specifically, overexpression of miR-34a suppresses the expression of target genes CDK4, CDK6, CyclinD1, and Bcl-2/Bax, which leads to cell cycle arrest and promotes apoptosis of lung adenocarcinoma cells. Conclusions: Overall, our results demonstrate that the overexpression of miR-34a enhances the radiosensitivity of lung adenocarcinoma cells, indicating that miR-34a is a sensitizer for lung adenocarcinoma radiotherapy.
